Boadie Dunlop, MD
Enriched profileProfessor and Department Chair, Department of Psychiatry and Health Behavior, Medical College of Georgia · Medical College of Georgia at Augusta University
Boadie Dunlop is Professor and Department Chair, Department of Psychiatry and Health Behavior, Medical College of Georgia at Medical College of Georgia at Augusta University. OpenAlex indexes 331 publications with 13,463 citations (h-index 55); ClinicalTrials.gov lists 8 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Psychiatry profiles in the findmyKOL directory.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Boadie Dunlop, MD, is Professor and Department Chair, Department of Psychiatry and Health Behavior, Medical College of Georgia at Medical College of Georgia at Augusta University. The public record shows 331 publications with 13,463 citations (h-index 55), centered on Treatment of Major Depression, Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes, Psychotherapy Techniques and Applications. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (2009–2018).
- Most recent indexed publication: 2026 · Military medicine
- Top research focus: Treatment of Major Depression
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 165.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 23 Oct 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
- LivaNova USA, Inc.Program year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year202412 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine23.5%Clonazepam48%Alprazolam34%Lorazepam18%Part D<11 patientsSSRI12.8%Trazodone Hcl46%Sertraline Hcl36%Paroxetine Hcl18%Part D<11 patients+ 11 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 23 Oct 2026
2 NIH research awards on record, funded 2009–2018 per NIH RePORTER. The latest:
- Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression
Duke University
FY2019$642,447R01MH108348 - Metabolomic Signatures Predictive of Outcomes to Treatments for Major Depression
Duke University
FY2018$670,790R01MH108348 - Testing an Imaging Biomarker for Treatment Stratification in Major Depression
Emory University
FY2018$513,803R01MH073719
Publications
Updated 23 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Neuroanatomical dimensions in major depression linked to cognition, adverse life events, self-harm, metabolomics and genetics.
Communications medicine
Article2025 - Medication use is associated with distinct microbial features in anxiety and depression.
Molecular psychiatry
Article2025 - Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort.
Translational psychiatry
Article2025
Most-cited works
by citation count (OpenAlex)- 01The Role of Dopamine in the Pathophysiology of DepressionArticle1,239 citations2007
- 02Single-Dose Psilocybin for a Treatment-Resistant Episode of Major DepressionArticle1,159 citations2022
- 03Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive DisorderArticle560 citations2013
- 04Single-Dose Psilocybin Treatment for Major Depressive DisorderArticle535 citations2023
- 05
Network
Updated 23 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 23 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
augusta.edu/colleges/medicine/psychiatry/about.php
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu ↗ - Other
augusta.edu/faculty/directory/view.php
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →augusta.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu ↗
Editorial & leadership roles
journal and society appointments- Deputy Editor
Psychopharmacology Bulletin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medworksmedia.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medworksmedia.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Charles Nemeroff, MD
Dell Medical School
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
Raquel Gur, MD
University of Pennsylvania